Literature DB >> 34023955

Awaji criteria for the diagnosis of amyotrophic lateral sclerosis in Hanoi, Vietnam.

Tuan Van Nguyen1, Tuan Anh Tran2,3, Hinh Thi Vu4.   

Abstract

The aim of the article was to evaluate the role of electromyography and the value of Awaji criteria for the diagnosis of ALS in the early stage. The study involves 48 patients (27 male and 21 females from 41 to 84 years old) who went to Bach Mai Hospital and Dong Do Clinic in Hanoi and were diagnosed with ALS according to Awaji criteria. All patients underwent clinical examination for ALS. The patients were examined for nerve conduction (motor and sensory conduction) using needle electromyography (EMG). Upper motor neuron (UMN) signs and lower motor neuron (LMN) signs were most common in the cervical region (89.58%), the lumbosacral region (70.83%), and the bulbar region (56.25%). The sensory nerve conduction was normal. The spontaneous activities (fasciculation, fibrillation, positive wave) accounted for more than 50% in all 4 regions: bulbar, cervical, thoracic, and lumbosacral regions. The abnormality of both clinical and electrodiagnosis was seen in the cervical region (87.5%) and lumbosacral one (70.83%) while the bulbar region and thoracic one usually had abnormal electrodiagnosis before clinical. There were 60.42% of patients with "definite ALS" by Awaji criteria. It allowed to make an earlier diagnosis cause the sensitivity of Awaji criteria (93.75%) was higher than the revised El Escorial criteria (85.42%) (p < 0.05). The needle EMG makes it possible to detect the early-stage symptoms of ALS in a situation where there are no clinical manifestations, especially in bulbar and thoracic regions.
© 2021. Fondazione Società Italiana di Neurologia.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Awaji criteria; Electromyography; Revised El Escorial criteria

Mesh:

Year:  2021        PMID: 34023955     DOI: 10.1007/s10072-021-05333-9

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  16 in total

Review 1.  El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.

Authors:  B R Brooks; R G Miller; M Swash; T L Munsat
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-12

Review 2.  Patterns of Weakness, Classification of Motor Neuron Disease, and Clinical Diagnosis of Sporadic Amyotrophic Lateral Sclerosis.

Authors:  Jeffrey M Statland; Richard J Barohn; April L McVey; Jonathan S Katz; Mazen M Dimachkie
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

Review 3.  The phenotypic variability of amyotrophic lateral sclerosis.

Authors:  Bart Swinnen; Wim Robberecht
Journal:  Nat Rev Neurol       Date:  2014-10-14       Impact factor: 42.937

4.  A revision of the El Escorial criteria - 2015.

Authors:  Albert Ludolph; Vivian Drory; Orla Hardiman; Imaharu Nakano; John Ravits; Wim Robberecht; Jeremy Shefner
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2015-06-29       Impact factor: 4.092

Review 5.  Motor Neuron Disease: Pathophysiology, Diagnosis, and Management.

Authors:  Laura A Foster; Mohammad Kian Salajegheh
Journal:  Am J Med       Date:  2018-08-01       Impact factor: 4.965

Review 6.  Amyotrophic lateral sclerosis: moving towards a new classification system.

Authors:  Ammar Al-Chalabi; Orla Hardiman; Matthew C Kiernan; Adriano Chiò; Benjamin Rix-Brooks; Leonard H van den Berg
Journal:  Lancet Neurol       Date:  2016-10       Impact factor: 44.182

Review 7.  Electrodiagnostic criteria for diagnosis of ALS.

Authors:  Mamede de Carvalho; Reinhard Dengler; Andrew Eisen; John D England; Ryuji Kaji; Jun Kimura; Kerry Mills; Hiroshi Mitsumoto; Hiroyuki Nodera; Jeremy Shefner; Michael Swash
Journal:  Clin Neurophysiol       Date:  2007-12-27       Impact factor: 3.708

8.  Amyotrophic lateral sclerosis in an urban setting: a population based study of inner city London.

Authors:  Clare A Johnston; Biba R Stanton; Martin R Turner; Rebecca Gray; Ashley Hay-Ming Blunt; David Butt; Mary-Ann Ampong; Christopher E Shaw; P Nigel Leigh; Ammar Al-Chalabi
Journal:  J Neurol       Date:  2006-12       Impact factor: 4.849

Review 9.  Advances in motor neurone disease.

Authors:  Dirk Bäumer; Kevin Talbot; Martin R Turner
Journal:  J R Soc Med       Date:  2014-01       Impact factor: 5.344

10.  A proposed staging system for amyotrophic lateral sclerosis.

Authors:  Jose C Roche; Ricardo Rojas-Garcia; Kirsten M Scott; William Scotton; Catherine E Ellis; Rachel Burman; Lokesh Wijesekera; Martin R Turner; P Nigel Leigh; Christopher E Shaw; Ammar Al-Chalabi
Journal:  Brain       Date:  2012-01-23       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.